Does DKC1 mutation suffice to define the phenotype severity of hoyeraal-hreidarsson syndrome? (2013)
- Authors:
- USP affiliated authors: ROXO JÚNIOR, PÉRSIO - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; TONE, LUIZ GONZAGA - FMRP
- Unidade: FMRP
- DOI: 10.4236/ojbd.2013.31012
- Subjects: MEDULA ÓSSEA; MUTAÇÃO GENÉTICA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Open Journal of Blood Diseases
- ISSN: 2164-3180
- Volume/Número/Paginação/Ano: v. 3, n. 1, p. 57-61, 2013
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
VALERA, Elvis Terci et al. Does DKC1 mutation suffice to define the phenotype severity of hoyeraal-hreidarsson syndrome?. Open Journal of Blood Diseases, v. 3, n. 1, p. 57-61, 2013Tradução . . Disponível em: https://doi.org/10.4236/ojbd.2013.31012. Acesso em: 07 maio 2024. -
APA
Valera, E. T., Brassesco, M. S., Ferraz, S. T., Roxo Junior, P., Santana, B. L., Vulliamy, T., et al. (2013). Does DKC1 mutation suffice to define the phenotype severity of hoyeraal-hreidarsson syndrome? Open Journal of Blood Diseases, 3( 1), 57-61. doi:10.4236/ojbd.2013.31012 -
NLM
Valera ET, Brassesco MS, Ferraz ST, Roxo Junior P, Santana BL, Vulliamy T, Calado RT, Scrideli CA, Tone LG. Does DKC1 mutation suffice to define the phenotype severity of hoyeraal-hreidarsson syndrome? [Internet]. Open Journal of Blood Diseases. 2013 ; 3( 1): 57-61.[citado 2024 maio 07 ] Available from: https://doi.org/10.4236/ojbd.2013.31012 -
Vancouver
Valera ET, Brassesco MS, Ferraz ST, Roxo Junior P, Santana BL, Vulliamy T, Calado RT, Scrideli CA, Tone LG. Does DKC1 mutation suffice to define the phenotype severity of hoyeraal-hreidarsson syndrome? [Internet]. Open Journal of Blood Diseases. 2013 ; 3( 1): 57-61.[citado 2024 maio 07 ] Available from: https://doi.org/10.4236/ojbd.2013.31012 - Dificuldades diagnósticas da doença de Kostmann: relato de caso
- Inibição do crescimento e redução da capacidade clonogênica em linhagens celulares de glioblastomas pediátricos e adultos através do DHMEQ
- Acute lymphoblastic leukemia analyzed by comparative genome hybridization(CGH)
- mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia, low expression levels associated with a higher risk of toxic death
- microRNA expression in childhood acute lymphoblastic leukemia: identification of microRNAs involved in leukemogenesis and prognosis
- Decreased expression of BATF2 is significantly associatedwith poor prognosis in childhood medulloblastoma
- Analysis of molecular pathways by Rnaseq following GDF15 knockdown in paediatric and adult glioblastoma cell lines
- Tetraploidization in Wilms tumor in an infant
- Bloom's and myelodysplastic syndromes: report of a rare pediatric case with gain of an isochromosome 5p. [Carta]
- Alternative targets for medulloblastoma treatment: polo-like kinase 1
Informações sobre o DOI: 10.4236/ojbd.2013.31012 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
